Year-end Sale % OFF 
Abstract
The choice of empiric antimicrobial therapy for community-acquired respiratory infections is based on pathogens most likely to be encountered. β-Lactam antibiotics are commonly used for both upper and lower respiratory tract infections, and can, in most cases, be used as monotherapy against nonatypical pathogens. Doxycycline, a semisynthetic, second generation tetracycline, has a high degree of activity against all common respiratory pathogens including ampicillin-sensitive-resistant Haemophilus influenzae, β-lactamase-producing strains of Moraxella catarrhalis, and oral pigmented Bacteroides as well as organisms commonly causing atypical pneumonias, eg, Mycoplasma pneumoniae, Legionella pneumophila, or Chlamydia pneumoniae (TWAR agent).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
